Cancer-related Pain
11
3
3
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
9.1%
1 terminated out of 11 trials
66.7%
-19.8% vs benchmark
9%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (11)
Developing a Multimodal Cancer Pain Database to Support AI-Based Automatic Pain Assessment
A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain
Trauma-Informed Procedural Pain Intervention: Refinement of an Evidence-Based Protocol
Neurolytic Block Techniques In Abdominal Visceral Cancer Pain
Buprenorphine for Cancer Pain
Integrating Auricular Point Acupressure Into Real-world Nursing Practice to Manage Cancer-related Pain
A Consensus on Opioid Prescription for Oncologic Patients in Latin America - A DELPHI Study.
The Effectiveness of Progressive Muscle Relaxation Technique in Reducing Cancer-related Pain
Stochastic Modulated Vibrations on Autonomic Nervous System of Breast Cancer Patients During Radiotherapy
Subcutaneous Lidocaine For Cancer-Related Pain
Exploring the Link Between Cancer Genetics and PPSP